The National Treatment Purchase Fund (NTPF) hopes to complete the recruitment process for a new CEO in March, the Medical Independent (MI) has been informed.
Mr Liam Sloyan left the role in December following his appointment by the Government as Financial Services and Pensions Ombudsman.
According to September 2022 meeting minutes of the NTPF board, obtained by this newspaper through Freedom of Information law, the Public Appointments Service (PAS) was contacted by the NTPF about managing the recruitment process for a new CEO.
However, the PAS “confirmed that they were not in a position to support the NTPF in recruiting a new Chief Executive at this time”.
The recruitment process is being managed by Lansdowne Executive Search Limited, which was selected following a tender process in line
with the Office of Government Procurement Framework.
“The position is being recruited through an open recruitment process, which was advertised from 9 December 2022 to 12 January 2023,” a spokesperson for the NTPF told MI.
“It is hoped that the recruitment process will be completed in March and an appointment made shortly thereafter.”
The salary for the post is €148,468 and the appointment will be on a five-year fixed-term contract.
“The appointed person will have the capacity and commitment to build on the NTPF’s achievements to date and will oversee the continued development and implementation of NTPF’s strategy through a dynamic working relationship with the board, the NTPF team, and all other relevant stakeholders,” according to the recruitment document.
The successful candidate should have a track record of “substantial achievement and delivery” at senior management level in the health sector, civil or public service or in the private sector.
Mr Sean Flood, Finance Director at the NTPF, has been appointed as interim CEO by the board pending the new CEO taking up the role.
The NTPF’s annual budget is in the region of €100 million and it employs approximately 90 staff.